Petrina Kamya, Ph.D., is the VP, Global Head of AI Platforms and President of Insilico Medicine Canada, overseeing Insilico’s end-to-end generative AI-driven drug discovery platform, Pharma.AI. Before joining Insilico, Dr. Kamya's career spanned many key stages of the drug discovery value chain from the early stages to commercialization. She holds a Ph.D. in chemistry and a BS in biochemistry from Concordia University.